Understanding Cancer Treatment Drugs: Chemotherapy, Hormone, Targeted & Immunotherapy

When a cancer diagnosis is made, several therapeutic pathways may be considered. Your oncologist might suggest chemotherapy, hormone therapy, targeted agents, immunotherapy, or a combination of these modalities, each chosen to match the biology of your tumor.

Oncologic pharmaceuticals encompass four major categories:

• Chemotherapy agents that attack rapidly dividing cells.
• Hormone therapies that block or modify hormonal signals driving tumor growth.
• Targeted therapies that interrupt specific molecular pathways essential to cancer cells.
• Immunotherapies that empower the immune system to recognize and destroy malignant cells.

Supportive medications are also prescribed to mitigate side effects caused by these treatments.

Chemotherapy

Chemotherapy drugs work by destroying fast‑growing cells throughout the body, aiming to reduce the total tumor burden and lower the risk of metastasis. In some curable cancers, chemotherapy can be the definitive cure. Physicians may administer a single agent or a regimen of multiple drugs, delivered via injection, topical application, or oral tablets.

The U.S. Food and Drug Administration (FDA) has approved nearly 300 anticancer drugs, many of which are chemotherapeutic agents.

Hormone Therapy

Hormone‑dependent cancers—such as certain breast and prostate cancers—rely on hormonal signals for growth. Hormone therapy interferes with these signals, either by blocking hormone receptors or by reducing hormone production.

These agents are often combined with surgery or radiation to improve outcomes.

Targeted Therapy

Targeted agents represent the core of precision medicine. By blocking specific genetic mutations or protein receptors unique to a tumor, they can inhibit cancer growth while sparing most normal cells.

Before prescribing a targeted drug, oncologists perform genetic or biomarker testing to confirm that the tumor possesses the relevant molecular target.

Immunotherapy

Immunotherapies harness the patient’s own immune system to locate and eliminate cancer cells. Some tumors evade immune detection; these drugs disrupt that evasion.

Available as intravenous infusions or oral capsules, immunotherapies may be used alone or in combination with other treatments, depending on the cancer type.

Supportive Medications

To address treatment‑related side effects, oncologists may prescribe:

• Growth‑factor agents such as pegfilgrastim (Neulasta) or filgrastim (Neupogen) to prevent neutropenia and infection.
• Anti‑nausea drugs.
• Pain‑relief medications.

Discuss with your doctor which supportive drugs are appropriate for your regimen.

Benefits of Cancer Drugs

Depending on the disease, these medications can:

• Prevent metastatic spread.
• Slow tumor progression.
• Shrink tumors to facilitate surgery.
• Alleviate pressure on vital structures (e.g., spinal cord).
• Eliminate residual cancer cells after surgery or radiation.
• Enhance the effectiveness of other therapies.
• Achieve cure in curable cancers.
• Reduce mortality risk.

Risks and Side Effects

Chemotherapy indiscriminately attacks dividing cells, which can lead to fatigue, hair loss, gastrointestinal upset, and lowered blood counts. Targeted therapies and immunotherapies generally have a more favorable side‑effect profile but may still cause issues such as skin rash, liver enzyme elevation, or autoimmune reactions.

Hormone therapies can produce hot flashes, fatigue, breast tenderness, decreased libido, mood changes, nausea, and diarrhea.

Complementary Approaches

Adjunctive practices—such as acupuncture, meditation, or certain herbal supplements—may help manage side effects, but they do not treat cancer itself. Always consult your oncologist before adding complementary therapies.

Patient Involvement in Treatment Decisions

You have the right to participate actively in your care, including delaying or declining treatment and seeking second opinions. Request reputable resources to inform yourself before making choices.

Exploring Experimental Options

Ask your physician about clinical trials. The National Institutes of Health maintains a searchable database at clinicaltrials.gov, and the National Cancer Institute offers a trial‑matching service (800‑4‑CANCER).

How Doctors Choose a Treatment Plan

Oncologists base recommendations on:

• The cancer type and histology.
• Stage or grade of disease.
• Molecular characteristics of the tumor.
• Patient age and overall health.
• Guidelines from authoritative bodies such as the National Comprehensive Cancer Network (NCCN).

Diagnostic work‑up may include imaging, blood tests, and molecular profiling. The final plan often integrates drug therapy with surgery, radiation, or other modalities.

Before proceeding, ask detailed questions about expected benefits, potential risks, and alternative options to ensure an informed, shared decision.